See veebileht kasutab küpsiseid kasutaja sessiooni andmete hoidmiseks. Veebilehe kasutamisega nõustute ETISe kasutustingimustega. Loe rohkem
Olen nõus
HUMAN ANTI-IFN-ALPHA ANTIBODIES
Patentne leiutis: HUMAN ANTI-IFN-ALPHA ANTIBODIES ; Omanikud: IMMUNOQURE AG; Autorid: Syeda Haque, Adrian Hayday, Kai Krohn, Annalisa Macagno, Steffen Meyer, Pärt Peterson, Mike Rothe, Philip Vlaicu, Martin Woodward, Kai Kisand; Prioriteedi number: EP20130174995 20130703; Prioriteedi kuupäev: 3.07.2013.
Patentne leiutis
HUMAN ANTI-IFN-ALPHA ANTIBODIES
HUMAN ANTI-IFN-ALPHA ANTIBODIES
Provided are novel IFN-[alpha] binding molecules of human origin, particularly human-derived anti-IFN-[alpha] antibodies as well as IFN-[alpha] binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits and methods for use in diagnosis and therapy are described.
  • Syeda Haque
  • Adrian Hayday
  • Kai Krohn
  • Annalisa Macagno
  • Steffen Meyer
  • Pärt Peterson
  • Mike Rothe
  • Philip Vlaicu
  • Martin Woodward
  • Kai Kisand
  • IMMUNOQURE AG
Prioriteeditaotlus
3.07.2013
EP20130174995 20130703
Euroopa (ECLA)
international: C07K16/24 cooperative: A61K51/1021; C07K16/249; G01N33/564; G01N33/6866; A61K2039/505; C07K2316/96; C07K2317/24; C07K2317/55; C07K2317/565; C07K2317/567; C07K2317/92; C07K2319/00; G01N2333/56
C07K16/24
Saksamaa Liitvabariik
Kaitstud
Järgnevad taotlused (1)
KuupäevNumberPatendiametRiikURLFailStaatus
3.07.2014PCT/EP2014/064167WIPOKaitstud